Study to Assess Safety and Efficacy of PRI-002 in Patients With MCI to Mild Dementia Due to Alzheimer's Disease (AD)

NCT06182085 · clinicaltrials.gov ↗

PHASE2

Phase

ACTIVE_NOT_RECRUITING

Status

304

Enrollment

INDUSTRY

Sponsor class

Conditions

Mild Cognitive Impairment Due to Alzheimer's Disease
Alzheimer's Disease, Early Onset

Interventions

DRUG: PRI-002
DRUG: Placebo

Sponsor

PRInnovation GmbH

Collaborators

[object Object]
[object Object]
[object Object]